PS Ratio: 65.35

Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

Is the P/S ratio high or low?

The P/S ratio of 65.35 is 133% above its estimated 5-year average of 28.00, around the middle of its estimated 5-year range (5.55–116.01).

As of 2026-10-06T20:07:06.837Z. 7.53% above its estimated 12-month average of 60.78.

IMDX PS Ratio Metrics

P/S vs. estimated history

At 65.35, P/S is above its estimated 6-year median — higher than 69% of readings in its estimated 6-year history.

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

Sales Valuation

PS Ratio Formula & Definition

PS Ratio = Market Cap / Revenue (TTM)

The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PS Ratio FAQ

What is the P/S ratio for Insight Molecular Diagnostics Inc. (IMDX)?

The P/S ratio for IMDX stock is 65.35.

Is Insight Molecular Diagnostics Inc.'s P/S ratio high or low?

The P/S ratio of 65.35 is 133% above its estimated 5-year average of 28.00, around the middle of its estimated 5-year range (5.55–116.01).

What is the estimated TTM average P/S ratio for Insight Molecular Diagnostics Inc. (IMDX)?

The estimated TTM average P/S ratio for IMDX stock is 60.78.

What is the estimated 3Y average P/S ratio for Insight Molecular Diagnostics Inc. (IMDX)?

The estimated 3Y average P/S ratio for IMDX stock is 32.76.

What is the estimated 5Y average P/S ratio for Insight Molecular Diagnostics Inc. (IMDX)?

The estimated 5Y average P/S ratio for IMDX stock is 28.00.

Showing the most recent 260 of 1,607 data points. The chart above shows the full history.

Related Metrics